ALEX ZWIERZYNSKI: Open Payments
NPI 1043826282 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,165 in 275 payments from 20 companies in 2025. Trend: 2023 $10,977 · 2024 $18,670 · 2025 $8,165
Food & beverage: $4,768Consulting: $2,550Travel & lodging: $736Education: $111
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $3,592 |
| ABBVIE INC. | 46 | $850 |
| Janssen Biotech, Inc. | 31 | $627 |
| LEO Pharma Inc. | 18 | $437 |
| Incyte Corporation | 27 | $431 |
| UCB, Inc. | 28 | $410 |
| Novartis Pharmaceuticals Corporation | 24 | $383 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $293 |
| E.R. Squibb & Sons, L.L.C. | 16 | $222 |
| Regeneron Healthcare Solutions, Inc. | 11 | $211 |
Products named: EBGLYSS, TREMFYA, SKYRIZI, OPZELURA, Bimzelx, COSENTYX, ADBRY, DUPIXENT.
Industry payments across NY — which companies pay providers there.
